NEW YORK, Jan. 22, 2016 /PRNewswire/ --
GoPro Inc. (GPRO)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the GPRO board. Specifically, GPRO expects fourth quarter sales to fall 31% annually to $435 million, well below its prior forecast for a 13% to 21% decline. Full-year sales are expected to rise 16% annually to $1.6 billion, down from 41% growth in fiscal 2014.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Iconix Brand Group (ICON)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the ICON board. On December 28, 2015, ICON announced it has received a formal order of investigation from the SEC. On November 5, 2015, ICON announced it would slash guidance for the full-year 2015, and revealed it would restate financial results for the fiscal years 2013-2015.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Inland Real Estate Corporation (IRC)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of IRC to Funds Managed by DRA Advisors LLC at $10.60 per share.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Nobilis Health Corp. (HLTH)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the HLTH board. The investigation relates to whether Nobilis's financial statements contained numerous errors concerning the Company's classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Sarepta Therapeutics, Inc. (SRPT)
Lifshitz & Miller announces investigation on behalf of investors of SRPT. Specifically, the FDA contends the data does not make a convincing case that eteplirsen works in the target patient group or that it accomplishes what it was designed to do.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Synutra International Inc. (SYUT)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the "going-private" offer by the SYUT Chairman and CEO and his affiliated entity to purchase Syut for $5.91 per share.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Wilshire Bancorp Inc. (WIBC)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of WIBC to BBCN Bancorp, Inc. valued at approximately $13.00 per share.
For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-gopro-inc-iconix-brand-group-inland-real-estate-corporation-nobilis-health-corp-sarepta-therapeutics-inc-synutra-international-inc-and-wilshire-bancorp-inc-300208497.html
SOURCE Lifshitz & Miller Law Firm
